Rigel Pharmaceuticals
RIGL
#6719
Rank
$0.48 B
Marketcap
$27.41
Share price
0.70%
Change (1 day)
242.63%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): -$6.53 Million USD

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are $0.13 Billion USD. In 2023 the company made an earning of -$18.22 Million USD, an increase over its 2022 earnings that were of -$54.87 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$6.53 Million-64.2%
2023 -$18.22 Million-66.79%
2022 -$54.87 Million340.73%
2021 -$12.45 Million-56.15%
2020 -$28.4 Million-57.34%
2019 -$66.56 Million-7.66%
2018 -$72.08 Million-9.47%
2017 -$79.62 Million24.46%
2016 -$63.98 Million23.63%
2015 -$51.75 Million-43.29%
2014 -$91.25 Million2.5%
2013 -$89.03 Million
2010 $37.85 M-133.97%
2009 -$0.12 Billion-18.49%
2008 -$0.14 Billion71.91%
2007 -$79.53 Million84.74%
2006 -$43.05 Million-10.17%
2005 -$47.93 Million-15.73%
2004 -$56.87 Million39.29%
2003 -$40.83 Million10.3%
2002 -$37.02 Million48.3%
2001 -$24.97 Million-2.13%
2000 -$25.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.14 Billion 1,902.15%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.21 Billion 3,065.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.40 B-144,236.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
$4.67 B-71,830.80%๐Ÿ‡บ๐Ÿ‡ธ USA